The latest research from Fore Pharma, Global Asthma Market and Competitive Landscape – 2020, provides comprehensive insights into Asthma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Asthma market size and drug sales. It also provides insights into Asthma epidemiology and late stage pipeline.
This research covers the following – Asthma treatment options, Asthma late stage clinical trials pipeline, Asthma prevalence by countries, Asthma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).
Research Scope:
– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Asthma pipeline: Find out drugs in clinical trials for Asthma by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Asthma epidemiology: Find out number of patients diagnosed (prevalence) with Asthma by countries
– Asthma drugs: Identify key drugs marketed and prescribed for Asthma by countries, including trade name, molecule name, and company
– Asthma drugs sales: Find out the sales value for Asthma drugs by countries
– Asthma market valuations: Find out the market size for Asthma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Asthma drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Asthma drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Asthma market
– Develop in-depth knowledge of competition and markets
– Analyze Asthma drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Asthma market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Asthma Treatment Options
2. Asthma Pipeline Insights
2.1. Asthma Phase 3 Clinical Trials
2.2. Asthma Phase 2 Clinical Trials
2.3. Asthma Phase 1 Clinical Trials
3. Asthma Epidemiology Analysis by Countries
4. US Asthma Market Insights
4.1. Marketed Drugs for Asthma in US
4.2. US Asthma Market Size & Forecast
4.3. US Asthma Drugs Sales & Forecast
4.4. US Asthma Market Share Analysis
5. Germany Asthma Market Insights
5.1. Marketed Drugs for Asthma in Germany
5.2. Germany Asthma Market Size & Forecast
5.3. Germany Asthma Drugs Sales Forecast
5.4. Germany Asthma Market Share Analysis
6. France Asthma Market Insights
6.1. Marketed Drugs for Asthma in France
6.2. France Asthma Market Size & Forecast
6.3. France Asthma Product Sales Forecast
6.4. France Asthma Market Share Analysis
7. Italy Asthma Market Insights
7.1. Marketed Drugs for Asthma in Italy
7.2. Italy Asthma Market Size & Forecast
7.3. Italy Asthma Product Sales Forecast
7.4. Italy Asthma Market Share Analysis
8. Spain Asthma Market Insights
8.1. Marketed Drugs for Asthma in Spain
8.2. Spain Asthma Market Size & Forecast
8.3. Spain Asthma Product Sales Forecast
8.4. Spain Asthma Market Share Analysis
9. UK Asthma Market Insights
9.1. Marketed Drugs for Asthma in UK
9.2. UK Asthma Market Size & Forecast
9.3. UK Asthma Product Sales Forecast
9.4. UK Asthma Market Share Analysis
10. Europe Asthma Market Insights
10.1. Europe Asthma Market Size & Forecast
10.2. Europe Asthma Product Sales Forecast
10.3. Europe Asthma Market Share Analysis
11. Japan Asthma Market Insights
11.1. Marketed Drugs for Asthma in Japan
11.2. Japan Asthma Market Size & Forecast
11.3. Japan Asthma Product Sales Forecast
11.4. Japan Asthma Market Share Analysis
12. Global Asthma Market Insights
12.1. Global Asthma Market Size & Forecast
12.2. Global Asthma Product Sales Forecast
12.3. Global Asthma Market Share Analysis
13. Research Methodology
List of Tables
1: Asthma Phase 3 Clinical Trials, Global, 2020
2: Asthma Phase 2 Clinical Trials, Global, 2020
3: Asthma Phase 1 Clinical Trials, Global, 2020
4: Asthma Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Asthma in US, 2019
6: US Asthma Market Size & Forecast ($mn), 2016 – 2025
7: US Asthma Product Sales ($mn), 2016 – 2025
8: US Asthma Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Asthma in Germany, 2019
10: Germany Asthma Market Size & Forecast ($mn), 2016 – 2025
11: Germany Asthma Product Sales ($mn), 2016 – 2025
12: Germany Asthma Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Asthma in France, 2019
14: France Asthma Market Size & Forecast ($mn), 2016 – 2025
15: France Asthma Product Sales ($mn), 2016 – 2025
16: France Asthma Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Asthma in Italy, 2019
18: Italy Asthma Market Size & Forecast ($mn), 2016 – 2025
19: Italy Asthma Product Sales ($mn), 2016 – 2025
20: Italy Asthma Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Asthma in Spain, 2019
22: Spain Asthma Market Size & Forecast ($mn), 2016 – 2025
23: Spain Asthma Product Sales ($mn), 2016 – 2025
24: Spain Asthma Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Asthma in UK, 2019
26: UK Asthma Market Size & Forecast ($mn), 2016 – 2025
27: UK Asthma Product Sales ($mn), 2016 – 2025
28: UK Asthma Market Events and Trends, 2016 – 2025
29: Europe Asthma Market Size & Forecast ($mn), 2016 – 2025
30: Europe Asthma Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Asthma in Japan, 2019
32: Japan Asthma Market Size & Forecast ($mn), 2016 – 2025
33: Japan Asthma Product Sales ($mn), 2016 – 2025
34: Japan Asthma Market Events and Trends, 2016 – 2025
35: Global Asthma Market Size & Forecast ($mn), 2016 – 2025
36: Global Asthma Product Sales ($mn), 2016 – 2025
List of Figures
1: Asthma Pipeline by Phase (%), Global, 2020
2: Asthma Prevalence by Countries, 2016 – 2025
3: US Asthma Market Size ($mn), 2016 – 2025
4: US Asthma Product Sales ($mn), 2016 – 2025
5: US Asthma Market Share by Drugs (%), 2019
6: US Asthma Market – Future Market Share (%), 2025
7: Germany Asthma Market Size ($mn), 2016 – 2025
8: Germany Asthma Product Sales ($mn), 2016 – 2025
9: Germany Asthma Market Share by Drugs (%), 2019
10: Germany Asthma Market – Future Market Share (%), 2025
11: France Asthma Market Size ($mn), 2016 – 2025
12: France Asthma Product Sales ($mn), 2016 – 2025
13: France Asthma Market Share by Drugs (%), 2019
14: France Asthma Market – Future Market Share (%), 2025
15: Italy Asthma Market Size ($mn), 2016 – 2025
16: Italy Asthma Product Sales ($mn), 2016 – 2025
17: Italy Asthma Market Share by Drugs (%), 2019
18: Italy Asthma Market – Future Market Share (%), 2025
19: Spain Asthma Market Size ($mn), 2016 – 2025
20: Spain Asthma Product Sales ($mn), 2016 – 2025
21: Spain Asthma Market Share by Drugs (%), 2019
22: Spain Asthma Market – Future Market Share (%), 2025
23: UK Asthma Market Size ($mn), 2016 – 2025
24: UK Asthma Product Sales ($mn), 2016 – 2025
25: UK Asthma Market Share by Drugs (%), 2019
26: UK Asthma Market – Future Market Share (%), 2025
27: Europe Asthma Market Size ($mn), 2016 – 2025
28: Europe Asthma Product Sales ($mn), 2016 – 2025
29: Europe Asthma Market Share by Drugs (%), 2019
30: Europe Asthma Market – Future Market Share (%), 2025
31: Japan Asthma Market Size ($mn), 2016 – 2025
32: Japan Asthma Product Sales ($mn), 2016 – 2025
33: Japan Asthma Market Share by Drugs (%), 2019
34: Japan Asthma Market – Future Market Share (%), 2025
35: Global Asthma Market Size ($mn), 2016 – 2025
36: Global Asthma Product Sales ($mn), 2016 – 2025
37: Global Asthma Market Share by Drugs (%), 2019
38: Global Asthma Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.